Orchid Pharma Ltd. - Research Center
524372 ORCHPHARMA Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
381.68 |
296.24 |
339.53 |
217.45 |
227.57 |
Operating profit |
45.84 |
30.27 |
45.37 |
11.89 |
39.71 |
Interest |
9.34 |
17.06 |
11.24 |
20.77 |
26.92 |
Gross profit |
46.57 |
21.98 |
38.24 |
-3.99 |
15.00 |
EPS (Rs) |
6.12 |
-4.27 |
-2.64 |
1.46 |
-5.01 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
10.07 |
8.77 |
4.11 |
4.89 |
2.20 |
Stock adjustment |
-1.87 |
-55.01 |
14.30 |
-37.03 |
-35.22 |
Raw material |
236.27 |
225.13 |
180.06 |
156.74 |
125.39 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
33.41 |
32.31 |
29.98 |
30.22 |
36.40 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
68.02 |
63.54 |
69.81 |
55.62 |
61.29 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
15.55 |
39.39 |
46.85 |
40.17 |
59.58 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
31.02 |
-17.41 |
-10.77 |
5.97 |
-44.59 |
Extra ordinary item |
- |
- |
-2.16 |
50.13 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
50.72 |
40.82 |
40.82 |
40.82 |
88.96 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
12.01 |
10.22 |
13.36 |
5.47 |
17.45 |
GPM (%) |
11.89 |
7.21 |
11.13 |
-1.80 |
6.53 |
NPM (%) |
7.92 |
-5.71 |
-3.14 |
2.68 |
-19.41 |